Sbir topic 328, in vitro assay of the initiation of breast cancer metastasis

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201400025C
Awardee
Awarding agency
Obligated
$223,048

Award facts

Opportunity
Contract value 100% obligated
$223,048.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541711 Research and Development in Biotechnology
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 22 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
San Diego, CA 92121, USA

Award details come from SAM.gov/FPDS.

About this award

This is a $223,048 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI) to Vala Sciences Inc., a small business, to develop an in vitro assay to study the initiation of breast cancer metastasis. The contract is a firm fixed-price definitive contract. Vala Sciences has previously received SBIR and project grant awards from the National Institutes of Health (NIH) to develop screening platforms and assays for pharmaceutical testing using human-derived cells, including assays for analgesics, neurotoxicity, and cardiotoxicity.

Quick answers

Who was awarded contract HHSN261201400025C?

HHSN261201400025C was awarded to Vala Sciences Inc. by National Cancer Institute (National Institutes of Health) on September 12, 2014.

How much is contract HHSN261201400025C worth?

The government has obligated $223,048 on HHSN261201400025C.

Was contract HHSN261201400025C competed?

The extent of competition for HHSN261201400025C was full and open competition after exclusion of sources. The government received 22 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award